Drug intelligence / Profile preview

hebanthe eriantha methanolic extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

Hebanthe eriantha methanolic extract is a **botanical research extract** prepared from the roots of *Hebanthe eriantha*, also known as suma or Brazilian ginseng. It is not a defined single-entity pharmaceutical but a complex plant-derived mixture reported to contain constituents such as pfaffosides and pfaffic acid. In preclinical academic studies, the extract showed **in vitro antiproliferative activity** against human colon cancer HCT116 cells and mouse breast tumor 4T1 cells, and **antibacterial activity** against *Staphylococcus aureus* and *Proteus vulgaris*. Its mechanism of action has not been established at a defined molecular target level; any observed effects are likely due to multi-component phytochemical activity rather than a validated, target-specific drug mechanism. There is no clear evidence of commercial clinical development, branding, or pharmaceutical manufacturing for this specific extract.

Other names
hebanthe eriantha methanolic extractsuma root methanolic extractbrazilian ginseng methanolic extract

Beyond the preview

Go deeper on hebanthe eriantha methanolic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hebanthe eriantha methanolic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call